Subjective and cardiovascular effects of cocaine during treatment with amantadine and baclofen in combination.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Psychiatry Research

• Publication date

  2007-08-30

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.PSYCHRES.2006.03.012PMID 17449110
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dopamine agonists for cocaine dependence.

  2010cited by this paper
• Role of GABAB receptor in alcohol dependence: Reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics

  2009cited by this paper
• Safety and efficacy of γ‐vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction

  2005cited by this paper
• Effects of GABAergic modulators on food and cocaine self-administration in baboons.

  2005cited by this paper
• Preclinical evidence for GABAB agonists as a pharmacotherapy for cocaine addiction.

  2005cited by this paper
• The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat

  2004cited by this paper
• Baclofen attenuates conditioned locomotion to cues associated with cocaine administration and stabilizes extracellular glutamate levels in rat nucleus accumbens.

  2003cited by this paper
• Dopamine agonists for cocaine dependence.

  2003cited by this paper
• Amantadine does not modulate reinforcing, subjective, or cardiovascular effects of cocaine in humans.

  2003cited by this paper
• Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use.

  2003cited by this paper
• Baclofen antagonizes nicotine‐, cocaine‐, and morphine‐induced dopamine release in the nucleus accumbens of rat

  2003cited by this paper
• A potential role for GABA(B) agonists in the treatment of psychostimulant addiction.

  2002cited by this paper
• GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings.

  2002cited by this paper
• A screening trial of amantadine as a medication for cocaine dependence.

  2002cited by this paper
• Amantadine in the treatment of cocaine-dependent patients with severe withdrawal symptoms.

  2000cited by this paper
• Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli

  1999cited by this paper
• Open-Channel Blockers at the Human α4β2 Neuronal Nicotinic Acetylcholine Receptor

  1998cited by this paper
• A novel strategy for the treatment of cocaine addiction

  1998cited by this paper
• Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor.

  1998cited by this paper
• Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.

  1997cited by this paper
• Amantadine inhibits nicotinic acetylcholine receptor function in hippocampal neurons.

  1997cited by this paper
• Amantadine in the early treatment of cocaine dependence: a double-blind, placebo-controlled trial.

  1996cited by this paper
• Inhibitory effect of MK-801 on amantadine-induced dopamine release in the rat striatum.

  1996cited by this paper
• Microdialysis studies with amantadine and memantine on pharmacokinetics and effects on dopamine turnover.

  1995cited by this paper
• Cocaine reward and cocaine craving: the role of dopamine in perspective.

  1994cited by this paper
• Amantadine increases the extracellular dopamine levels in the striatum by re-uptake inhibition and by N-methyl-D-aspartate antagonism.

  1994cited by this paper
• The Fifth Edition of the Addiction Severity Index.

  1992cited by this paper
• Using cue reactivity to screen medications for cocaine abuse: a test of amantadine hydrochloride.

  1992cited by this paper
• Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on N-methyl-D-aspartate-evoked acetylcholine release in the rabbit caudate nucleus in vitro.

  1992cited by this paper
• Amantadine may facilitate detoxification of cocaine addicts.

  1992cited by this paper
• Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence.

  1991cited by this paper
• Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence.

  1991cited by this paper

• Integrative Pharmacology in the Treatment of Substance Use Disorders

  2023cites this paper
• Sustained drug delivery strategies for treatment of common substance use disorders: Promises and challenges.

  2022cites this paper
• GABAB Receptors and Drug Addiction: Psychostimulants and Other Drugs of Abuse.

  2021cites this paper
• Dopamine agonists for the treatment of cocaine dependence.

  2015cites this paper
• Drugs currently in Phase II clinical trials for cocaine addiction

  2014cites this paper
• Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research

  2014influential citation
• Behavior of knock-in mice with a cocaine-insensitive dopamine transporter after virogenetic restoration of cocaine sensitivity in the striatum.

  2014cites this paper
• Novel roles for the GABAB receptor in anxiety and cocaine addiction

  2013cites this paper
• Efficacy and Tolerability of Baclofen in Substance Use Disorders: A Systematic Review

  2013cites this paper
• Anatomy and Pharmacology of Dopamine Transporter-Mediated Reward and Locomotor Responses to Psychostimulants

  2012cites this paper
• Neuroimaging as a Biomarker for the Diagnosis, Progression, and Treatment of Substance Abuse Disorders

  2012cites this paper
• A single-day paradigm of self-regulated human cocaine administration.

  2012cites this paper
• Inactivation of the dorsal raphé nucleus reduces the anxiogenic response of rats running an alley for intravenous cocaine.

  2011cites this paper
• Dopamine agonists for the treatment of cocaine dependence.

  2011cites this paper
• Novel pharmacological approaches to drug abuse treatment.

  2010cites this paper
• Chemistry and pharmacology of GABAB receptor ligands.

  2010cites this paper
• The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers.

  2009cites this paper
• Renin and aldosterone but not the natriuretic peptide correlate with obsessive craving in medium-term abstinent alcohol-dependent patients: a longitudinal study.

  2008cites this paper
• Medication Development for the Treatment of Substance Abuse

  2008cites this paper